Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New model for vascular and tumour research

21.12.2015

VOGIM cell culture technique allows tumour growth to be observed

Two characteristic features of malignant tumours are that they form massive blood vessels and bypass the immune system. A new cell culture technique allows the processes of tumour growth to be studied directly and in real time, without the need for complex experiments using live animals.


Tumour-induced cell death and tumour zones I and II. The tumour is shown in green, damaged neurons are shown in red and cell nuclei are shown in blue.

The researchers at Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) who developed the technique looked specifically at brain tumours. The team led by neuroscientist PD Dr. Nicolai Savaskan developed a 3D cell culture technique called the Vascular Organotypic Glioma Impact Model (VOGIM) which allows the formation of tumour blood vessels and their interaction with immune cells to be observed over a period of several days in an organotypic context.

This new method will allow new medications and therapies to be analysed directly, and enable side effects to be identified more quickly and efficiently than when using conventional cell culture techniques. VOGIM also allows the amount of animal testing required in vascular studies to be reduced. The results of the study by researchers at the Department of Neurosurgery at Universitätsklinikum Erlangen have now been published in the journal ONCOTARGET.

'VOGIM is a complex technique that allows tumours to be studied in real time and under clinically realistic conditions – without the need for live animal testing,' says Dr. Nicolai Savaskan, who led the study. In the technique tissue samples from rodent brains are infected with tumour cells expressing fluorescent reporter genes.

The growth of tumour cells and blood vessels, cell death, and the influence of medications on these developments are observed in the experiment. 'Even though VOGIM still requires some animal testing, it is a great technique. It can be used to test the effectiveness of new medications and molecules against gliomas – tumours of the central nervous system – relatively quickly and in a way that is reproducible,' Dr. Savaskan explains.

'We can also use it to study the side effects of almost any medication.' The next goal of the Erlangen-based researchers is to test new hybrid molecules from the plant and animal kingdom in this system in order to quickly develop new treatment strategies.

Brain tumours have destructive effects on the surrounding cells and blood vessels. Accumulations of serum around the tumour are a common symptom. These cause swelling in the brain and increase pressure inside the skull to dangerous levels.

In the worst case, the swelling can cause pressure on the respiratory centre above the cervical spine, quickly leading to suffocation. The cause of this swelling in the brain are pathological changes to the tumour blood vessels and disruption of the immune response to the brain tumour.

The accumulations of serum are caused by the tumour cells which damage surrounding tissue and cells, making them more permeable. The new VOGIM technique allows the tumour blood vessels and the immune system of the brain to be observed closely and the influence of new therapeutics to be studied in this context.

Original publication: Ali Ghoochani, Eduard Yakubov, Tina Sehm, Zheng Fan, Stefan Hock, Michael Buchfelder, Ilker Y. Eyüpoglu, Nicolai E. Savaskan: A versatile ex vivo technique for assaying tumor angiogenesis and microglia in the brain. ONCOTARGET 2015.
DOI: 10.18632/oncotarget.6550
Full text: http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=a...

Further information:
PD Dr. Nicolai Savaskan
Phone: +49 9131 8544748
nicolai.savaskan@uk-erlangen.de

Patient information:
Phone: +49 9131 8549000
krebsinformation@uk-erlangen.de

Dr. Susanne Langer | idw - Informationsdienst Wissenschaft
Further information:
http://www.fau.de/

More articles from Health and Medicine:

nachricht 'Exciting' discovery on path to develop new type of vaccine to treat global viruses
18.09.2017 | University of Southampton

nachricht A new approach to high insulin levels
18.09.2017 | Schweizerischer Nationalfonds SNF

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Ultrafast snapshots of relaxing electrons in solids

Using ultrafast flashes of laser and x-ray radiation, scientists at the Max Planck Institute of Quantum Optics (Garching, Germany) took snapshots of the briefest electron motion inside a solid material to date. The electron motion lasted only 750 billionths of the billionth of a second before it fainted, setting a new record of human capability to capture ultrafast processes inside solids!

When x-rays shine onto solid materials or large molecules, an electron is pushed away from its original place near the nucleus of the atom, leaving a hole...

Im Focus: Quantum Sensors Decipher Magnetic Ordering in a New Semiconducting Material

For the first time, physicists have successfully imaged spiral magnetic ordering in a multiferroic material. These materials are considered highly promising candidates for future data storage media. The researchers were able to prove their findings using unique quantum sensors that were developed at Basel University and that can analyze electromagnetic fields on the nanometer scale. The results – obtained by scientists from the University of Basel’s Department of Physics, the Swiss Nanoscience Institute, the University of Montpellier and several laboratories from University Paris-Saclay – were recently published in the journal Nature.

Multiferroics are materials that simultaneously react to electric and magnetic fields. These two properties are rarely found together, and their combined...

Im Focus: Fast, convenient & standardized: New lab innovation for automated tissue engineering & drug

MBM ScienceBridge GmbH successfully negotiated a license agreement between University Medical Center Göttingen (UMG) and the biotech company Tissue Systems Holding GmbH about commercial use of a multi-well tissue plate for automated and reliable tissue engineering & drug testing.

MBM ScienceBridge GmbH successfully negotiated a license agreement between University Medical Center Göttingen (UMG) and the biotech company Tissue Systems...

Im Focus: Silencing bacteria

HZI researchers pave the way for new agents that render hospital pathogens mute

Pathogenic bacteria are becoming resistant to common antibiotics to an ever increasing degree. One of the most difficult germs is Pseudomonas aeruginosa, a...

Im Focus: Artificial Enzymes for Hydrogen Conversion

Scientists from the MPI for Chemical Energy Conversion report in the first issue of the new journal JOULE.

Cell Press has just released the first issue of Joule, a new journal dedicated to sustainable energy research. In this issue James Birrell, Olaf Rüdiger,...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

“Lasers in Composites Symposium” in Aachen – from Science to Application

19.09.2017 | Event News

I-ESA 2018 – Call for Papers

12.09.2017 | Event News

EMBO at Basel Life, a new conference on current and emerging life science research

06.09.2017 | Event News

 
Latest News

“Lasers in Composites Symposium” in Aachen – from Science to Application

19.09.2017 | Event News

New quantum phenomena in graphene superlattices

19.09.2017 | Physics and Astronomy

A simple additive to improve film quality

19.09.2017 | Power and Electrical Engineering

VideoLinks
B2B-VideoLinks
More VideoLinks >>>